MICROCEPHALY |
|
|
|
|
|
|
|
|
Cell cycle: Centro-some formation, spindle orientation, microtubule organization, cytokinesis |
MCPH1 |
AR |
Premature chromosome condensation, decreased neuronal proliferation, premature differentiation |
SIMP |
Congenital MIC |
+ |
- |
- |
|
ASPM |
AR |
Decreased neuronal proliferation |
Decreased brain volume, SIMP |
Congenital MIC |
- |
- |
+/- |
|
WDR62 |
AR |
Decreased neuronal proliferation |
MCDs, complex |
Congenital MIC, cortical dysplasia |
- |
- |
- |
|
CD-K5RAP2 |
AR |
Premature differentiation |
Decreased brain volume, SIMP |
Congenital MIC |
- |
- |
- |
|
CASC5 |
AR |
Decreased neuronal proliferation |
Decreased brain volume, SIMP |
Congenital MIC |
- |
- |
- |
|
CENPJ |
AR |
Increased apoptosis |
Decreased brain volume, SIMP |
Congenital MIC, Seckel syndrome |
+ |
- |
+ |
|
SASS6** |
AR |
Decreased neuronal proliferation, exact neuronal phenotype not well-understood |
Decreased brain volume, SIMP |
Congenital MIC |
- |
- |
+ |
|
STIL |
AR |
Neural tube defects, increased sensitivity to neurotoxic insult |
Holoprosencephaly, SIMP |
Congenital MIC |
- |
- |
- |
|
CEP152 |
AR |
Abnormal centrosome structure and function, decreased neuronal proliferation |
Decreased brain volume, SIMP |
Congenital MIC, Seckel syndrome |
+ |
- |
- |
|
CEP63** |
AR |
Increased cell death due to increased centrosome-based mitotic errors. |
Decreased brain volume, SIMP |
Seckel syndrome |
+ |
- |
- |
|
NDE1 |
AR |
Decreased neuronal proliferation |
MCDs, complex |
Microhydranencephaly, lissencephaly |
+ |
- |
- |
|
NIN |
AR |
Defects of the anterior neuroectoderm |
Decreased brain volume, SIMP |
Seckel syndrome |
+ |
- |
- |
|
PCNT |
AR |
Disorganized mitotic pindles and misaggregation of chromosomes, decreased neuronal proliferation |
Decreased brain volume, SIMP, vascular abnormalities |
MOPD type II |
+ |
- |
- |
|
BUB1B |
AR |
Decreased neuronal proliferation, increased apoptosis |
Complex |
Mosaic variegated aneuploidy |
+ |
+ |
- |
|
CENPE |
AR |
Potential defect of neuronal proliferation |
Decreased brain volume, SIMP |
Congenital MIC, MOPD |
+ |
- |
- |
Centro-some formation, spindle orientation, micro-tubule organization, cytokinesis |
KIF5C |
AD/ de novo |
Abnormal microtubule function |
Complex |
Cortical dysplasia |
- |
- |
+ |
|
KIF2A |
AD/ de novo |
Abnormal axonal branching with consequently reduced neuronal volume |
Complex |
Cortical dysplasia |
+ |
- |
+ |
|
KIF11 |
AD/ de novo |
Abnormal mitotic spindles, decreased neuronal proliferation |
Decreased brain volume, SIMP |
Microcephaly-chorioretinopathy-lymphedema |
- |
- |
- |
|
KIF14 |
AR |
Increased neuronal apoptosis, impaired cell migration and motility, decreased myelination |
Decreased brain volume, large basal cisterns, optic nerve atrophy |
Congenital MIC, Meckel syndrome |
+ |
- |
- |
|
TUBA1A |
AD/ de novo |
Abnormal neuronal migration |
Complex |
Tubulinopathy |
- |
- |
+ |
|
TUBG1 |
AD/ de novo |
Abnormal neuronal migration |
Complex |
Tubulinopathy |
- |
- |
- |
|
TUBB2B |
AD/ de novo |
Abnormal neuronal migration |
Complex |
Tubulinopathy |
- |
- |
- |
|
TBCD |
AR |
Abnormal microtubule structure and function with likely effects on neuronal proliferation and migration |
Complex |
Encephalopathy, atrophy, thin corpus callosum |
+ |
- |
+ |
|
POC1A |
AR |
Abnormal mitotic spindles and centrioles with likely effects on neuronal proliferation and migration |
- |
Short stature, on-ychodysplasia, facial dysmorphism, hypotrichosis |
+ |
- |
- |
|
ZNF335 |
AR |
Reduced proliferation, defects of neuronal differentiation and migration |
SIMP |
Congenital MIC |
+ |
- |
- |
|
CIT |
AR |
Impaired neuronal cytokinesis, delayed mitosis, cellular blebbing, multipolar spindles, genome instability, increased apoptosis |
Complex |
Congenital MIC |
- |
- |
- |
|
NCAPD2 |
AR |
Impaired chromosome segregation, reduced neuronal proliferation, reduced cell survival |
Decreased brain volume, SIMP |
Congenital MIC |
+ |
- |
- |
|
NCAPD3 |
AR |
Impaired chromosome segregation, reduced neuronal proliferation, reduced cell survival |
|
|
- |
- |
- |
|
NCAPH** |
AR |
Impaired chromosome segregation, reduced neuronal proliferation, reduced cell survival |
|
|
- |
- |
- |
|
KATNB1 |
AR |
Supernumerary centrosomes and spindle abnormalities |
Decreased brain volume, SIMP, cortical dysplasia |
Congenital MIC, cortical dysplasia |
- |
- |
+ |
Cell cycle: kinetochore |
CEP135 |
AR |
Fragmented or lack of centrosomes with disorganized microtubules, decreased neuronal proliferation |
Decreased brain volume, SIMP |
Congenital MIC |
- |
- |
- |
|
CENPF |
AR |
Abnormal spindle orientation and ciliogenesis |
Decreased brain volume, SIMP |
Stromme syndrome |
- |
- |
- |
|
CHAMP1 |
AD/ de novo
|
Abnormal kinetochore-microtubule attachment |
Decreased brain volume, SIMP |
Intellectual disability, microcephaly |
- |
- |
- |
Cell cycle: mitotic chromosome structure |
NCAPD2 |
|
Abnormal chromosome condensation, and sister chromatid disentanglement |
Decreased brain volume, SIMP |
AR microcephaly |
+ |
- |
- |
|
NCAPH |
AR |
|
Decreased brain volume, SIMP |
AR microcephaly |
- |
- |
- |
|
NCAPD3 |
AR |
|
Decreased brain volume, SIMP |
AR microcephaly |
+ |
- |
|
Origin Recognition Complex |
ORC1 |
AR |
Abnormal DNA replication and likely abnormal neuronal proliferation |
SIMP |
MGORS |
+ |
- |
- |
|
ORC4 |
AR |
|
SIMP |
MGORS |
+ |
- |
- |
|
ORC6 |
AR |
|
SIMP |
MGORS |
+ |
- |
- |
|
CDT1 |
AR |
|
SIMP |
MGORS |
+ |
- |
- |
|
CDC6 |
AR |
|
SIMP |
MGORS |
+ |
- |
|
|
GMNN |
AR |
|
SIMP |
MGORS |
+ |
- |
- |
|
CDC45 |
AR |
|
SIMP |
MGORS |
+ |
- |
- |
DDR and chromosome stability and cell cycle regulation |
ATR |
AR/AD |
Exact neuronal phenotype not well-understood |
Complex |
Seckel syndrome, Familial cancer |
+ |
- |
- |
|
ATRIP |
AR |
Exact neuronal phenotype not well-understood |
SIMP |
Seckel syndrome |
+ |
- |
- |
|
RBBP8 |
AR |
Exact neuronal phenotype not well-understood |
Complex |
Seckel syndrome, Jawad syndrome |
+ |
- |
- |
|
NBN |
AR |
Aberrant regulation of early brain development |
SIMP |
Nijmegen breakage syndrome |
+ |
+ |
- |
|
RAD50 |
AR |
Exact neuronal phenotype not well-understood |
SIMP |
Nijmegen breakage syndrome-like disorder |
+ |
+ |
- |
|
MRE11A |
AR |
Exact neuronal phenotype not well-understood |
Complex |
Ataxia-telan-giectasia-like disorder |
- |
+ |
+ |
|
PNKP |
AR |
Increased neurogenesis, defects in neuronal differentiation |
Complex |
Microcephaly with seizures and developmental delay, ataxia-oculomotor apraxia |
- |
- |
+ |
|
BRCA1 |
AR |
Neuroepithelial defects, reduced proliferation |
SIMP |
Fanconi anemia, complementation group S |
- |
+ |
- |
DDR and chromosome stability and cell cycle regulation |
BRCA2 |
AR |
Reduced neuronal proliferation |
SIMP |
Fanconi anemia, complementation group D1 |
- |
+ |
- |
|
LIG4 |
AR |
Exact neuronal phenotype not well-understood |
SIMP |
LIG4 syndrome |
+ |
+ |
- |
|
NHEJ1 |
AR |
Exact neuronal phenotype not well-understood |
SIMP |
SCID with microcephaly |
+ |
+ |
- |
|
DDX11 |
AR |
Exact neuronal phenotype not well-understood |
SIMP |
Warsaw breakage syndrome |
+ |
+ |
- |
|
PHC1 |
AR |
Reduced proliferation, defects of differentiation |
SIMP |
Congenital MIC |
+ |
- |
- |
|
DNA2 |
AR |
Increased senescence, needs research |
SIMP |
Seckel syndrome |
+ |
- |
- |
|
XRCC2 |
AR |
Increased apoptosis of postmitotic neurons |
SIMP |
Fanconi anemia, complementation group U |
+ |
+ |
- |
|
XRCC4 |
AR |
Increased apoptosis, reduced proliferation |
Complex |
Short stature, microcephaly, and endocrine dysfunction |
+ |
+ |
- |
|
RECQL3 |
AR |
Exact neuronal phenotype not well-understood |
SIMP |
Bloom syndrome |
+ |
+ |
- |
|
DONSON |
AR |
Decreased neuronal proliferation |
SIMP, abnormal WM, and MCDs |
Microcephaly-micromelia syndrome |
+ |
- |
- |
|
STAMBP |
AR |
Increased apoptosis |
Complex |
Microcephaly-capillary malformation |
+ |
- |
+ |
|
CDK6 |
AR |
Exact neuronal phenotype not well-understood |
SIMP |
Congenital MIC |
- |
+ |
- |
|
ANKLE2 |
AR |
Decreased cell proliferation and increased apoptosis of neuroblasts |
SIMP, MCDs, ventricular abnormalities, ACC |
Congenital MIC |
+ |
- |
+ |
|
MFSD2A |
AR |
BBB defects, neuronal cell loss, loss of transport activity |
SIMP |
Congenital MIC |
+ |
- |
+ |
Cellular trafficking, fatty acid metabolism, lipid binding proteins |
WDFY3** |
AD |
Abnormal WNT activation, increased proliferation of apical progenitor cells, lack of neuronal differentiation, impaired cortical development (dominant-negative effect) |
MIC |
Congenital MIC |
- |
- |
- |
|
COPB2** |
AR |
Increased apoptosis, reduction of upper layer neurons |
SIMP, thin CC, enlarged XAX, delayed myelination, progressive atrophy |
Congenital MIC |
+ |
- |
+ |
MEGALENCEPHALY |
|
|
|
|
|
|
|
|
PI3K-AKT-MTOR |
PIK3 CA |
AD/de novo (mosaic) |
Exact neuronal phenotype understudy, likely cell hypertrophy, abnormal neuronal organization |
PMG (BPP) |
PIK3CA-related overgrowth disorders |
+ |
+/-(tentative, Wilms tumor) |
+ |
|
PTEN |
AD/ de novo
|
Cell hypertrophy |
PMG, FCD |
PTEN-hamarto-ma tumor syndrome |
+ |
+ |
- |
|
PIK3R2 |
AD/de novo |
Exact neuronal phenotype understudy, likely cell hypertrophy, abnormal neuronal organization |
PMG (BPP), mega CC |
Megalencephaly-polymicrogyria-polydactyly-hydrocephalus (MPPH) syndrome |
- |
- |
+ |
|
MTOR |
AD/de novo (mosaic) |
Cell hypertrophy, abnormal neuronal migration |
PMG/HMEG/FCD (depending on level of mosaicism) |
MTOR-related disorders |
- |
- |
+ |
|
CCND2 |
AD/de novo |
Increased neuronal proliferation |
PMG (BPP), mega CC |
MPPH syndrome |
- |
- |
+ |
|
RHEB |
AD/de novo |
Cell hypertrophy, abnormal migration |
- |
MEG-ID |
- |
- |
+ |
|
STRADA (LYK5) |
AR |
Abnormal neuronal lamination, mTORC1 hyperactivation |
VMEG, subependymal dysplasia, WM abnormalities |
Polyhydramnios-MEG-symptomatic epilepsy (PMSE) |
- |
- |
+ |
|
DEPDC5 |
AD/de novo |
Neuronal hypertrophy and abnormal neuronal organization |
FCD, MCDs |
Familial epilepsy |
- |
- |
+ |
|
AKT3*** |
AD/de novo (mosaic) |
Exact neuronal phenotype under study, likely cell hypertrophy, abnormal neuronal organization |
PMG/HMEG/FCD (depending on level of mosaicism) |
MPPH syndrome |
- |
- |
+ |
|
TSC1/TSC2 |
AD/de novo |
Neuronal hypertrophy |
Cortical tubers, subependymal nodules, HMEG/FCD |
Tuberous Sclerosis |
- |
+ |
+ |
DNA methyltrans-ferases, transcription initiation, and regulators |
NSD1*** |
AD/de novo |
Exact neuronal phenotype not well-understood |
VMEG,XAX |
Sotos syndrome |
+ |
- |
- |
|
EED |
AD/de novo |
Abnormal EZH2 function, exact neuronal phenotype not well understood |
- |
Cohen-Gibson syndrome |
+ |
- |
- |
|
DNMT3A |
AD/de novo |
Exact neuronal phenotype not well-understood |
|
Tatton-Brown-Rahman syndrome |
+ |
- |
+ |
|
EZH2 |
AD/de novo |
Exact neuronal phenotype not well-understood |
MCDs, VMEG |
Weaver syndrome |
+ |
- |
+ |
DNA methyl-trans-ferases, transcription initiation, and regulators |
MYCN*** |
AD/de novo |
Decreased apoptosis |
- |
2p24.3 duplication syndrome |
- |
+ (w/ amplifications) |
- |
|
MED12 |
X-linked |
Exact neuronal phenotype not well-understood |
Callosal abnormalities, VMEG, HET |
Opitz-Kaveggia syndrome Lujan (Lujan-Fryns) syndrome |
+ |
- |
+ |
|
NFIX |
AD/de novo
|
Exact neuronal phenotype not well-understood |
- |
Malan syndrome |
+ |
- |
+ |
|
SETD2 |
AD/ de novo
|
Exact neuronal phenotype not well-understood |
Likely complex |
Luscan-Lumish syndrome |
+/- |
- |
+ |
RAS-MAPK |
NF1 |
AD/ de novo
|
RAS-MAPK mediated effects on brain development (pleitropic) |
VMEG, UBOs on T2 imaging, CC abnormalities |
Neurofibromatosis type I |
- |
+ (Optic gliomas) |
- |
|
SPRED1 |
AD/ de novo
|
|
- |
Legius syndrome |
- |
- |
- |
|
HRAS |
AD/ de novo
|
|
CBTH, VMEG/ HYD |
Costello syndrome |
+ Short stature |
+ |
- |
|
BRAF, MAP2K1, MAP2K2, KRAS |
AD/ de novo
|
|
CBTH, VMEG/HYD, cortical atrophy, MCDs |
Cardiofaciocutaneous syndrome |
+ Short stature |
- |
- |
|
PTPN11, SOS1, RAF1, KRAS, BRAF, SHOC2, NRAS, MAP2K1 |
AD/ de novo
|
|
CBTH, VMEG/HYD |
Noonan syndrome |
+ Short stature |
- |
- |
|
RIN2 |
AR |
|
- |
Macrocephaly-alopecia-cutis laxa-scoliosis (MACS) syndrome |
+ Short stature |
- |
- |
|
RAB39 |
XL |
|
- |
XLID, ASD, epilepsy |
- |
- |
+ |
RTKs |
FGFR3 |
AR |
Abnormal neuronal proliferation and apoptosis of cortical progenitors |
HYD, cervico-medullary compression, MCDs, other |
Achondroplasia Thanatophoric dysplasia |
+ Multiple skeletal anomalies |
- |
- |
|
ROR2 |
AR |
Abnormal neuronal sternness |
MCDs |
Robinow syndrome |
+ Short stature |
- |
- |
NOTCH |
GPC3 |
X-linked |
Abnormal cell growth and proliferation, exact neuronal phenotype not well-understood |
HYD, cerebellar tonsillar herniation, CC abnormalities |
Simpson Golabi Behmel syndrome I |
+ |
+ (Embryonal tumors, Wilms tumor) |
|
|
NOTCH2NL*** |
AD/ de novo
|
Delayed neuronal differentiation |
- |
1q21.1 microduplication syndrome |
- |
- |
- |
SHH |
PTCH1 |
AD/ de novo
|
Abnormal neuronal proliferation and organization |
Calcifications (>90%) |
Nevoid basal cell carcinoma syndrome |
- |
+(PNET) |
- |
|
KIF7 |
AR |
Abnormal neuronal proliferation and organization |
CC abnormalities (ACC) |
Acrocallosal syndrome |
+ Growth retardation |
- |
+ |
|
GLI3 |
AD/ de novo
|
Abnormal neuronal proliferation |
CC abnormalities (ACC) |
Greig cephalosyndactyly |
- |
- |
- |
Cilia structure and function |
OFD1 |
X-linked |
Abnormal ciliary function in proliferating sells |
VMEG |
Simpson Golabi Behmel syndrome II |
+ |
- |
- |
|
RTTN |
AR |
Abnormal centriole formation |
Decreased brain volume, SIMP, cortical dysplasia, callosal, cerebellar abnormalities |
Microcephaly, short stature, and poly-microgyria with seizures |
+ |
- |
+ |
JAK-STAT |
BRWD3 |
X-linked |
Abnormal cell morphology and cytoskeletal organization |
- |
XLID |
- |
- |
- |
Abbreviations: |
|
|
|
|
|
|
|
|
ACC, agenesis of the corpus callosum; AD, autosomal dominant; AR, autosomal recessive; ASD, autism spectrum disorders; BPP, bilateral frontoparietal polymicrogyria; CBTH, cerebellar tonsillar herniation; CC, corpus callosum; FCD, focal cortical dysplasia; HET, heterotopia; HMEG, hemimegalencephaly; HYD, hydrocephalus; MCDs, malformations of cortical development; MCPH, primary microcephaly genes 1-23; MEG, megalencephaly; MGORS, Meier-Gorlin syndrome 1-7; MIC, microcephaly; MOPD, microcephalic osteodysplastic primordial dwarfism; PMG, polymicrogyria; RTKs, receptor tyrosine kinases; SCID; Severe Combined Immunodeficiency; SIMP, simplified gyral pattern; UBOs, unidentified bright objects on brain MRI; VMEG, ventriculomegaly; WM, white matter; XAX, extra-axial space; XLID, X-linked intellectual disability. |
|
|
|
|
|
|
|
|
Notes: |
|
|
|
|
|
|
|
|
* Cancer predisposition specifically refers to germline (constitutional) cancer risk |
|
|
|
|
|
|
|
|
** MIC-/MEG-associated mutations in these genes have been reported in one or few families, to date. |
|
|
|
|
|
|
|
|
*** Reciprocal deletions/duplications of these gene loci are associated with MIC or MEG and include the following genes: AKT3 (1q43.q44; del MIC, dup MEG); NOTCH2NL (1q21.1; del MIC, dup MEG), MYCN (2p.24.3; del MIC, dup MEG); NSD1 (5q35.3; del MEG, dup MIC). Other MIC-MEG loci include 10q22q23 (del MEG, dup MIC) and 16p11.2 (dup MIC, dup MEG) with no MIC/MEG candidate genes identified, to our knowledge. |
|
|
|
|
|
|
|
|